By inhibiting PFKFB3, aspirin overcomes sorafenib resistance in hepatocellular carcinoma.
Li S, Dai W, Mo W, Li J, Feng J, Wu L, Liu T, Yu Q, Xu S, Wang W, Lu X, Zhang Q, Chen K, Xia Y, Lu J, Zhou Y, Fan X, Xu L, Guo C.
Li S, et al. Among authors: zhou y.
Int J Cancer. 2017 Dec 15;141(12):2571-2584. doi: 10.1002/ijc.31022. Epub 2017 Sep 14.
Int J Cancer. 2017.
PMID: 28857200